BioCentriq secures $29.2M investment to accelerate cell therapy innovation
BioCentriq, a Newark-based cell-based therapy contract development and manufacturing organization, raised $29.2 million in Series A ...
Read more
BioCentriq, a Newark-based cell-based therapy contract development and manufacturing organization, raised $29.2 million in Series A ...
Read more